Work

Targeting BRD4 with BET inhibition synergizes with anti-HER2 therapy and overcomes resistance in HER2-amplified uterine serous cancer

Year: 2024

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2024.07.350

Authors: Shaheen Mahira, Mohamad Jawadi, Huseyin Karakilic, Philip Jones, Hayriye Baghaki, Alexander Olawaiye, Haider Mahdi

Institutions: Magee-Womens Hospital, University of Pittsburgh Medical Center

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403250762

FWCI: 0.136

Cites:

Cited by: 1

Related to: 10